Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications

Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 6

Abstract

Curcumin, an aromatic phytoextract from the turmeric (Curcuma longa) rhizome, has been used for centuries for a variety of purposes, not the least of which is medicinal. A growing body of evidence suggests that curcumin has a broad range of potentially therapeutic pharmacological properties, including anti-inflammatory, anti-fibrotic, and anti-neoplastic effects, among others. Clinical applications of curcumin have been hampered by quality control concerns and limited oral bioavailability, although novel formulations appear to have largely overcome these issues. Recent in vitro and in vivo studies have found that curcumin's cytoprotective and other biological activities may play a role in an array of benign and malignant hepatobiliary conditions, including but not limited to non-alcoholic fatty liver disease, cholestatic liver disease (e.g. primary sclerosing cholangitis), and cholangiocarcinoma. Here we provide an overview of fundamental principles, recent discoveries, and potential clinical hepatobiliary applications of this pleiotropic phytocompound.

Authors and Affiliations

Robert W. Hu, Elizabeth J. Carey, Keith D. Lindor, James H. Tabibian

Keywords

Related Articles

Meta-analysis of the clinical value of oxymatrine on sustained virological response in chronic hepatitis B

Introduction. Oxymatrine (OMTR) is widely used for the treatment of chronic hepatitis B (CHB) in China. Several recent reportsrevealed that OMTR together with interferon yielded a higher sustained virological response (...

Inter and intrapatient evolution of hepatitis C virus

Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because evolution can be visualized in rea...

MDR3 mutations associated with intrahepatic and gallbladder cholesterol cholelithiasis: an update

Background: The recurrent microlithiasis represents one of the most frequent clinical forms of lithiasis of the bile ducts. This affection is characterized by the presence of cholesterolic microgallstones on hepatic cana...

Download PDF file
  • EP ID EP228011
  • DOI 10.5604/01.3001.0010.5273
  • Views 107
  • Downloads 0

How To Cite

Robert W. Hu, Elizabeth J. Carey, Keith D. Lindor, James H. Tabibian (2017). Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications. Annals of Hepatology, 16(6), 835-841. https://europub.co.uk/articles/-A-228011